Published in Transplant Proc on March 01, 1978
Comparison of rates of virus isolation from leukocyte populations separated from blood by conventional and Ficoll-Paque/Macrodex methods. J Clin Microbiol (1979) 2.04
Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia. Blood (2011) 1.41
Natural resistance of lethally irradiated F1 hybrid mice to parental marrow grafts is a function of H-2/Hh-restricted effectors. J Exp Med (1984) 0.94
Genetic markers in human bone marrow transplantation. Am J Hum Genet (1980) 0.79
Bone marrow transplantation: a review. J Natl Med Assoc (1989) 0.79
Bone marrow transplantation in Canada. Can Med Assoc J (1980) 0.78
1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant (1995) 24.01
Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials (1989) 15.99
Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry (1988) 12.39
Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation (1974) 10.91
Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med (1995) 10.04
Opinion leaders vs audit and feedback to implement practice guidelines. Delivery after previous cesarean section. JAMA (1991) 9.71
Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med (1980) 9.64
Physiological migration of hematopoietic stem and progenitor cells. Science (2001) 7.02
Role-relationship models for case formulation. Arch Gen Psychiatry (1995) 5.87
An exceptionally conserved transcriptional repressor, CTCF, employs different combinations of zinc fingers to bind diverged promoter sequences of avian and mammalian c-myc oncogenes. Mol Cell Biol (1996) 5.74
Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med (2001) 5.59
Assessing health quality--the case for tracers. N Engl J Med (1973) 5.05
Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med (2001) 4.56
Levels of c-myc oncogene mRNA are invariant throughout the cell cycle. Nature (1985) 4.35
A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology (1989) 4.27
Bone-marrow transplantation (second of two parts). N Engl J Med (1975) 4.11
Methylation of mouse liver DNA studied by means of the restriction enzymes msp I and hpa II. Science (1979) 4.06
Bone marrow transplantation for sickle cell disease. N Engl J Med (1996) 4.02
A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet (1979) 4.01
Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant (2006) 3.78
Diagnosis of iron-deficiency anemia in the elderly. Am J Med (1990) 3.77
Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med (1979) 3.59
Expression of the c-myb proto-oncogene during cellular proliferation. Nature (1986) 3.45
Bone-marrow transplantation (first of two parts). N Engl J Med (1975) 3.33
Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis (1986) 3.31
Monoclonal antibodies to cytomegalovirus: rapid identification of clinical isolates and preliminary use in diagnosis of cytomegalovirus pneumonia. Infect Immun (1982) 3.22
Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med (1986) 3.22
Iron Metabolism. Heme Synthesis in Vitro by Immature Erythrocytes. Science (1949) 3.14
CTCF, a conserved nuclear factor required for optimal transcriptional activity of the chicken c-myc gene, is an 11-Zn-finger protein differentially expressed in multiple forms. Mol Cell Biol (1993) 3.08
A randomized trial of a family physician intervention for smoking cessation. JAMA (1988) 3.03
Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood (1981) 3.03
Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial. N Engl J Med (1985) 2.99
Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc (1974) 2.95
Measurement of endogenous leukosis virus nucleotide sequences in the DNA of normal avian embryos by RNA-DNA hybridization. Virology (1973) 2.94
Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med (1993) 2.91
The canine major histocompatibility complex. Supertypic specificities defined by the primed lymphocyte test (PLT). Immunogenetics (1984) 2.72
Indications for marrow transplantation in chronic myelogenous leukemia. Blood (1989) 2.72
Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N Engl J Med (1990) 2.66
Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis (1999) 2.65
Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. N Engl J Med (1981) 2.61
Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med (1989) 2.61
Nucleotide sequence relationships of avian RNA tumor viruses: measurement of the deletion in a transformation-defective mutant of Rous sarcoma virus. J Virol (1974) 2.61
Antigen CD34+ marrow cells engraft lethally irradiated baboons. J Clin Invest (1988) 2.53
Cation transport in Escherichia coli. VII. Potassium requirement for phosphate uptake. J Gen Physiol (1967) 2.52
Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes. J Exp Med (1981) 2.50
Nobel laureates' letter to President Bush. Washington Post (2001) 2.43
Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med (1989) 2.42
Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience. Rev Infect Dis (1983) 2.39
Development and testing of a new measure of health status for clinical trials in heart failure. J Gen Intern Med (1989) 2.39
One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood (1977) 2.36
Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med (1998) 2.36
Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis (1996) 2.33
A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment. Blood (1990) 2.32
5-Methylcytosine content of rat hepatoma DNA substituted with bromodeoxyuridine. J Biol Chem (1977) 2.32
Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood (1996) 2.30